|
|
|
Pozen says Texas court upholds Treximet patents
Court Watch |
2011/08/08 16:29
|
Drug developer Pozen Inc. said Monday that a Texas court upheld three patents supporting its migraine drug Treximet.
Pozen said the U.S. District Court for the Eastern District of Texas ruled that the patents were valid. The court also found that generic versions of Treximet developed by Par Pharmaceutical Co. and Dr. Reddy's Laboratories Ltd. infringed on all three patents, while a version developed by Alphapharm Pty Ltd. infringed on two patents. Teva Pharmaceutical Industries Ltd. had also challenged the patents, but was dismissed from Pozen's lawsuit in April 2010 after it agreed to abide by the court's decision.
The court said the Food and Drug Administration cannot approve the generics made by Dr. Reddy's and Par until Feb. 2, 2025, and that the agency can't approve the Alphapharm generic until Aug. 14, 2017.
Treximet is a combination of GlaxoSmithKline PLC's drug Imitrex and an anti-inflammatory drug developed by Pozen. GlaxoSmithKline markets the drug and pays royalties to Pozen. In the second quarter, those royalty payments accounted for $4 million of Pozen's $4.6 million in total revenue.
The FDA approved Treximet in April 2008 after years of delays, and Par filed for approval of its generic in October of that year. |
|
|
|
|
|
|
Lawyer pleads guilty to $47 million Ponzi scheme
Court Watch |
2011/08/06 16:16
|
An Arkansas lawyer and businessman admitted today to staging a Ponzi scheme that netted more than $47 million, a scam that a prosecutor called the largest case of fraud in state history.
Kevin Lewis, 43, pleaded guilty today to one count of bank fraud in federal district court in Little Rock. He could face up to 30 years in prison, though U.S. Attorney Christopher Thyer said Lewis would likely receive between 10 to 13 years.
He will also have to pay restitution of almost $40 million, though that number could go down further as banks work to recover their losses.
Lewis acknowledged that he issued paperwork for fake rural improvement bonds often used by developers to defraud several Arkansas banks starting with a small bond in 1997.
That money went to maintain his business interests across the state, which range from a law firm to a clothing company. He used the money to make the payments on past fake bonds and support a personal lifestyle that included a house valued at more than $1 million, fancy cars and vacations, Thyer said.
Meanwhile, the bank that bought almost $23 million of the fake bonds, First Southern Bank in Batesville, was placed into receivership by authorities, Thyer said. Lewis had purchased majority ownership of First Southern, using a loan from another Arkansas bank that was backed by the fake bonds. |
|
|
|
|
|
|
Calif. court hears appeal on gay juror dismissals
Court Watch |
2011/08/05 16:16
|
A federal appeals case pending in California could determine if trial lawyers should be barred from dismissing potential jurors because they are gay.
The U.S. 9th Circuit Court of Appeals heard arguments Thursday in Pasadena that challenge a Los Angeles prosecutor's decision to strike a lesbian from the jury in an assault case against a gay federal inmate.
The Los Angeles Times reports a favorable ruling could extend constitutional discrimination protections to homosexuality, along with race, creed and gender.
Inmate Daniel Osazuwa says he hugged a guard who was homophobic and he overreacted. The guard fell and Osazuwa landed on him.
A public defender argues the trial judge erred in dismissing a lesbian from the jury, but a prosecutor says she was let go for another legitimate reason. |
|
|
|
|
|
|
Parker Waichman Alonso LLP Files Class Action Lawsuits
Press Release |
2011/08/05 16:16
|
Parker Waichman Alonso LLP Files Two Class Action Lawsuits on Behalf of Iowa Property Owners Alleging DuPont's Imprelis™ Herbicide Killed and Damaged Trees on Their Property
Parker Waichman Alonso LLP, a national law firm representing victims of defective products and toxic substances, together with its partner law firms, has filed two class action lawsuits on behalf of Iowa residents alleging DuPont's Imprelis™ herbicide killed and damaged trees on their property. The first, brought by Daryl and Mary Ann Haley of Tipton, Iowa, was filed in U.S. District Court for the Northern District of Iowa, Cedar Rapids Division (Case No. 1:11-cv-00085-LRRR). A second Imprelis™ lawsuit was filed on behalf of Nicholas L. Peters of Mars, Iowa, in U.S. District Court for the Northern District of Iowa, Sioux City Division (Case No. 5:11-cv-04066-MWB). Both Complaints seeks class action status on behalf of property owners who have sustained damage as a result of Imprelis™.
Plaintiffs in both lawsuits allege Imprelis™ was applied to their lawns in accordance with directions and instructions supplied by DuPont. The Class Action Complaints allege that as a result of the Imprelis™ applications, the Plaintiffs suffered significant damage and harm to trees, and will continue to suffer even further damage to their lawn and garden because of Imprelis™. The lawsuits further allege that rather than being isolated incidents, thousands of trees have been reported as being infected by Imprelis™, and tens of thousands more reports are expected in the future.
Both lawsuits charge DuPont with, among other things, negligence, strict liability, breach of express warranty and breach of implied warranties. The Plaintiffs seek injunctive relief barring DuPont from continued sale of Imprelis™, and compensatory and other damages including the cost of replacing trees damaged by Imprelis™.
Imprelis™, brought to market by DuPont in October 2010, is designed to kill broadleaf weeds, including dandelion, clover and wild violet. It is touted by DuPont as an environmentally-friendly herbicide and an "innovative solution to control a wide spectrum of broadleaf weeds." According to a New York Times report, reports of dying trees possibly associated with Imprelis™ started surfacing around Memorial Day, and have since prompted warnings from extension services in several states. Imprelis™ is now suspected of causing the death of thousands of shallow-rooted trees, including willows, poplars and conifers, on lawns, golf courses, parks and cemeteries throughout the country. The reports have prompted the U.S. Environmental Protection Agency (EPA) to begin gathering information on the tree deaths from state officials and DuPont.
DuPont acknowledged it was investigating reports of tree deaths and damage possibly associated with Imprelis™ in a letter to turf management professionals dated June 17, 2011. On July 27, 2011, the company issued another letter stating that in the course of its review, “We have observed tree injuries associated with Imprelis™, primarily on Norway spruce and white pine trees.” The problems appear to be concentrated in Minnesota, Michigan, Indiana, Ohio, Pennsylvania, New Jersey and Wisconsin, DuPont said.
Parker Waichman Alonso LLP and its partner firms have now filed three class action lawsuits on behalf of property owners who claim to have sustained damage following application of Imprelis™. A previous lawsuit was filed on behalf of an Ohio property owner in U.S. District Court for the Northern District of Ohio, Eastern Division (Case No. 1:11-cv-01517).
Parker Waichman Alonso LLP continues to receive reports of Imprelis™ tree death and damage from around the country, including from homeowners, golf courses, universities, arboretums, nurseries and orchards, parks and recreational sites, and cemeteries. Parker Waichman Alonso LLP is investigating these complaints on behalf of property owners who have sustained damages as a result of Imprelis™. More information regarding Imprelis™ side effects can be obtained at Parker Waichman Alonso LLP's DuPont Imprelis™ poisoning page. The page will be updated regularly as more information becomes available.
For more information regarding Imprelis™ class action lawsuits and Parker Waichman Alonso LLP, please visit http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636). |
|
|
|
|
|
| Lawyer & Law Firm Websites |
|
|
Legal News RSS Feed
